Covid-19 epidemiology |
Epidemiology of Covid-19, including infection rates, patient demographics, risk factors, surveillance systems, modelling/predicting the spread of infection, transmission routes, patterns of infection, factors associated with mortality. May include some discussion of symptoms. |
Covid-19 health service provision |
Organisation, provision, staff or support of health services to deal with Covid-19 patients. Includes safety precautions in Covid-19 medical settings, and pharmaceutical industry developments. Excludes health-related increases/decreases in incidence (not reporting) due to pandemic conditions. |
Covid-19 impact on other health services |
Changes in uptake or provision of health services for purposes unrelated to Covid-19, such as cancer and surgery, due to Covid-19 healthcare or pandemic safety restrictions. |
Covid-19 medical treatment |
Treatments for patients infected with Covid-19, such as antivirals, plasma transfusion, and nutrition. Includes papers investigating properties of potential treatments. Includes articles discussing both diagnosis and treatment. |
Covid-19 safety precautions |
Methods or equipment to avoid transmission of Covid-19, other than lockdowns in general, including contact tracing, studies of the prevalence of safety measures or risk awareness (including in general medical training/settings), and urban planning. Risk and safety information communication. |
Covid-19 symptoms |
Common and rare symptoms, complications and side-effects of Covid-19 (including conditions “associated with” Covid-19), diagnosed at the time or post mortem, including invisible symptoms (blood changes) and studies of symptom progression over time. |
Covid-19 vaccines |
Development, testing, and rollout of Covid-19 vaccines |
Covid-19 virology |
Properties of the virus, transmission methods, genomics, mutations, receptors, animal origins, animal coronaviruses specifically linked to Covid-19. |
Covid-19 with another condition |
Identification or treatment of other conditions in conjunction with Covid-19 (not caused by Covid-19), including pregnancy; or discussion of other pre-existing conditions shown to exacerbate Covid-19 or to be a risk factor for it. |